MC4R and hyperinsulinism: Obese patients with Mc4r mutations have smaller prevalence of hypertension, reduced BP and reduced norepinephrine secretion, despite being severely obese and showing severe metabolic abnormalities, such as hyperphagia and hyperinsulinemia (Greenfield et al., 2009; Greenfield, 2011).